Ironwood Pharmaceuticals Reports Second Quarter 2020 Results; Delivered GAAP Net Income of $25 Million and Adjusted EBITDA of $33 Million

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. FDX
3. SPY
4. ABBV
5. META
6. ACN
7. BLZE
8. IBM
9. NKE
10. MU

Go back to Ironwood Pharmaceuticals Reports Second Quarter 2020 Results; Delivered GAAP Net Income of $25 Million and Adjusted EBITDA of $33 Million

Ironwood Pharma (IRWD) Tops Q2 EPS by 7c; Reinstates Guidance

August 6, 2020 7:45 AM EDT

Ironwood Pharma (NASDAQ: IRWD) reported Q2 EPS of $0.16, $0.07 better than the analyst estimate of $0.09. Revenue for the quarter came in at $89.43 million versus the consensus estimate of $86.24 million.

Grew LINZESS® (Iinaclotide) total prescription demand by 9% year-over-year; new-to-brand prescription demand grew >15% in June 2020 compared to March... More